¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"large cell lymphoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • mesenchymal cell
    Áß°£¿±¼¼Æ÷
  • mesothelial cell
    ÁßÇǼ¼Æ÷
  • microglial cell
    ¹Ì¼¼¾Æ±³¼¼Æ÷, ¼Ò±³¼¼Æ÷
  • natural killer cell leukemia
    ÀÚ¿¬»ìÇØ¼¼Æ÷¹éÇ÷º´
  • nerve cell
    ½Å°æ¼¼Æ÷
  • nerve cell body
    ½Å°æ¼¼Æ÷ü
  • nerve cell process
    ½Å°æ¼¼Æ÷µ¹±â
  • neural crest cell
    ½Å°æ´É¼±¼¼Æ÷
  • neuroendocrine cell
    ½Å°æ³»ºÐºñ¼¼Æ÷
  • neuroepithelial cell
    ½Å°æ»óÇǼ¼Æ÷
  • neuroglial cell
    ½Å°æ¾Æ±³¼¼Æ÷, ½Å°æ±³¼¼Æ÷
  • neurosecretory cell
    ½Å°æºÐºñ¼¼Æ÷
  • nevus cell
    ¸ð¹Ý¼¼Æ÷
  • nodal cell
    °áÀý¼¼Æ÷
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • round cell
    ¿øÇü¼¼Æ÷
  • satellite cell
    À§¼º¼¼Æ÷
  • scavenger cell
    û¼Ò¼¼Æ÷
  • Schwann¡¯s cell
    ½Å°æÁý¼¼Æ÷
  • sensitized cell
    ¹Î°¨¼¼Æ÷
  • sensory cell
    °¨°¢¼¼Æ÷
  • septal cell
    Á߰ݼ¼Æ÷
  • serous cell
    Àå¾×¼¼Æ÷
  • Sertoli cell
    (¢¡supporting cell) ¹öÆÀ¼¼Æ÷
  • sexual cell
    (¢¡germ cell) Á¾ÀÚ¼¼Æ÷, ¹è¾Æ¼¼Æ÷, »ý½Ä¼¼Æ÷
  • sickle cell
    ³´ÀûÇ÷±¸
  • signet ring cell carcinoma
    ¹ÝÁö¼¼Æ÷¾ÏÁ¾
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷
  • slide cell culture
    ½½¶óÀ̵弼Æ÷¹è¾ç
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷
  • inner phalangeal cell
    ¼Ó¼Õ°¡¶ô¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷(¡­á¬øà).
  • inner pillar cell
    ¼Ó±âµÕ¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷
  • inner sustentacular cell
    ¼Ó¹öÆÀ¼¼Æ÷
  • insulin secreting islet cell tumor
    Àν¶¸° ºÐºñ¼º µµ¼¼Æ÷Á¾¾ç.
  • interaction, T-B cell
    T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
  • interaction, T-T cell
    T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
  • persensitized cell
    °ú°¨ÀÛ¼¼Æ÷(ΦÊïíÂá¬øà)
  • petrous tip cell
    Ãßü÷ºÀ¼Ò.
  • photochemical cell
    ±¤È­ÇÐÀüÁö(ÎÃûùùÊ ï³ò®).
  • photoconductive cell
    ±¤Àüµµ¼ÒÀÚ(¡­áÈí­).
  • photoelectric cell
    ±¤ÀüÁö(ÎÃï³ò®).
  • physaliphorous cell
    ´ã°øÆ÷¼¼Æ÷(Ó½Íöøàá¬øà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cell mediated reaction
    ¼¼Æ÷¸Å°³¼º ¹ÝÀÀ.
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane
    ¼¼Æ÷¸·(á¬øàØ¯)
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º(á¬øàØ¯÷âΦàõ).
  • cell migration disorder
  • cell of parathyroid gland
    ºÎ°©»ó»ù¼¼Æ÷
  • cell of reticulum
    ¹úÁýÀ§Ä­
  • cell organelles
    ¼¼Æ÷¼Ò±â°ü
  • cell permeability
    ¼¼Æ÷Åõ°ú¼º
  • cell physiology
    ¼¼Æ÷»ý¸®ÇÐ
  • cell pole
    ¼¼Æ÷±Ø(á¬øàп)
  • cell pole
    ¼¼Æ÷±Ø(á¬øàп).
  • cell proliferation
    ¼¼Æ÷ Áõ½Ä
  • cell respiration
    ¼¼Æ÷È£Èí
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
LLETZ large loop excision of the transformation zone
LLR large local reaction; left lateral rectus [muscle]; left lumbar region
LML large and medium lymphocytes; left mediolateral; left middle lobe
LMP large multifunctional protease; last menstrual period; latent membrane potential; left mentoposterio...
LNAA large neutral amino acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
B cell cell
G cell gastrin cell
TCR 1(+)-T-cell receptor
TCC Transitional Cell Carcinoma
VCAM-1 1/vascular cell adhesion molecule-1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • prickle cell layer
    ±Ø¼¼Æ÷ Ãþ, À¯±Ø ¼¼Æ÷Ãþ, °¡½ÃÃþ, À¯±ØÃþ
    ÀÎÁ¢ ¼¼Æ÷¿Í ¼¼Æ÷°£±³¸¦ Çü¼ºÇϰí ÀÖ´Â °¢È­ ±¸°­ »óÇÇÀÇ ÇÑ ¼¼Æ÷Ãþ.
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primitive myoid cell
    ¿ø½Ã ±Ù ¼Ò¼¼Æ÷
  • primordial germ cell
    ¿ø½Ã »ý½Ä¼¼Æ÷, ½Ã¿ø »ý½Ä ¼¼Æ÷
    »ý¹°ÀÇ ¹ß»ý Ãʱ⿡ ÀåÂ÷ »ý½Ä¼Ò·Î ºÐÈ­µÉ ¿¹Á¤ÀÎ ¼¼Æ÷¿ª¿¡ À־ÀÇ ¹ÌºÐÈ­ »ý½Ä ¼¼Æ÷. ¿ø½Ã »ý½Ä ¼¼Æ÷, ½Ã¿ø¼º ¼¼Æ÷¶ó°íµµ ÇÑ´Ù. ¹ß»ýÀÌ ÁøÇàµÇ¸é »ý½Ä¼ÒÀÇ ³­¿ø ¼¼Æ÷ ¶Ç´Â Á¤¿ø ¼¼Æ÷·Î ºÐÈ­ÇÑ´Ù. ½Ã¿ø »ý½Ä ¼¼Æ÷´Â ´Ù¸¥ Á¶Á÷ ¼¼Æ÷¿Í ±¸º°µÇ´Â ÇüÅÂÀû Ư¡À» °¡Áö¸ç, ¶ÇÇÑ »ý½Ä¼ÒÀÇ ¿¹Á¤¿ªº¸´Ù »ó´çÈ÷ ¶³¾îÁø ¹è¿ª¿¡ Á¸ÀçÇÑ´Ù. ÀÌ ¹è¿ª¿¡ Àå¾Ö¸¦ ÁÖ¸é »ý½Ä ¼¼Æ÷ÀÇ ºÐÈ­°¡ ÀϾÁö ¾Ê°Ô µÈ´Ù. ½Ã¿ø »ý½Ä ¼¼Æ÷´Â ü¼¼Æ÷¿Í´Â ¸í¹éÇÏ°Ô ±¸º°µÇ¸ç, ü¼¼Æ÷·ÎºÎÅÍ ½Ã¿ø »ý½Ä ¼¼Æ÷·Î ºÐÈ­µÇÁö ¾Ê´Â´Ù°í ÇÏ´Â »ý½ÄÁú ¿¬¼Ó¼³ÀÌ ÀϹÝÀûÀ¸·Î ÀÎÁ¤µÇ°í ÀÖ´Ù. ¿¹¸¦ µé¸é, ¸»È¸ÃæÀº 2°³ÀÇ ¿°»öü¸¦ °¡Áö´Âµ¥, À̰ÍÀº ÃÖÃÊÀÇ ³­ºÐÇÒ ¶§ºÎÅÍ »ý½Ä ¼¼Æ÷°è¿Í ü¼¼Æ÷°è·Î ³ª´©¾îÁø´Ù. »ý½Ä ¼¼Æ÷°è´Â 2°³ÀÇ ¿°»öü¸¦ °¡Áö°í ¿¬¼ÓÇÏÁö¸¸, ü¼¼Æ÷°è´Â ¿°»öü¿¡ Àý´ÜÀÌ ÀϾ¼­ ´Ù¼öÀÇ ¿°»öü ¼ö¸¦ °¡Áö´Â ¼¼Æ÷°è·Î ºÐÈ­ÇÑ´Ù.
  • principal cell
    ÁÖ ¼¼Æ÷
  • projection cell
    Åõ»ç ¼¼Æ÷
  • proliferating cell pool

    proliferating pleurisy (Áõ½Ä¼º È丷¿°

  • pyknotic endothelial cell
    ³óÃà ÇÙ ³»ÇÇ ¼¼Æ÷
  • pyramidal cell
    ÇǶó¹Ô ¼¼Æ÷, Ãßü ¼¼Æ÷, ÇǶó¹Ô ¸ð¾ç ¼¼Æ÷
    ºÎ¼öµÈ ¼¶À¯¿Í °°ÀÌ Ãßü ½Å°æ¿øÀ» ±¸¼ºÇϰí ÀÖ´Â ´ë³ú ÇÇÁúÀÇ Å©°í ´Ù±Ø¼ºÀÎ ÃßüÇü ½Å°æÀý ¼¼Æ÷ÀÇ Çϳª.
  • R-S cell
    ¸®µå-½ºÅÙ¹ö±× ¼¼Æ÷
    È£µåŲ½ºº´¿¡¼­ ³ªÅ¸³ª´Â ´ÙÇÙ °Å´ë ¼¼Æ÷.
  • red blood cell
    ÀûÇ÷±¸
    µ¿ÀǾî=erythrocyte. »ê¼Ò³ª ÀÌ»êȭź¼Ò¸¦ ¿î¹ÝÇÏ´Â Ç÷¾× ³»¿¡ Á¸ÀçÇÏ´Â Ç÷±¸.
  • red cell volume
    ÀûÇ÷±¸ ¿ëÀû
    ü³»ÀÇ ÃÑÀûÇ÷±¸ ¿ë·®À¸·Î¼­ ¹æ»ç´É µ¿À§¿ø¼Ò·Î ÃøÁ¤ÇÑ´Ù.
  • Reed-sternberg cell
    ¸®µå-½ºÅϹö±× ¼¼Æ÷
    Hodgkinº´¿¡ Ư¡ÀûÀÎ Ä¿´Ù¶õ ÀÌÇü Á¶Á÷±¸ÀÌ´Ù. ÀüÇüÀûÀÎ ¼¼Æ÷´Â ´ã¿°¼ºÀÇ È£»ê¼º ¼¼Æ÷ÁúÀ» °¡Áö¸ç, 1-2°³ÀÇ ´ëÇü ÇÙ ¶Ç´Â Áö³ªÄ¡°Ô ºÐ¿±ÇÑ ÇÙÀ» °®´Â´Ù. ±× ÇÙÀº º¯¿¬ºÎ¿¡´Â ¿°»öÁúÀÇ µ¢¾î¸®¿Í ºñÁ¤»óÀûÀ¸·Î ÇöÀúÇÑ È£»ê¼ºÀÇ ÇÙ¼Òü¸¦ °¡Áö°í ÀÖ´Ù. ÀÌÇÙ¼ºÀÇ °ÍÀº °¡²û °æ»óÇüÀ» ³ªÅ¸³½´Ù.
  • renal cell carcinoma
    ½Å ¼¼Æ÷ ¾ÏÁ¾
  • renomedullary interstitial cell tomor
    ½Å ¼öÁú °£Áú ¼¼Æ÷Á¾ Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
M cell <cell biology> An autonomous self replicating unit (in principle) that may constitute an organism (in the case of unicellular organisms) or be a sub unit of multicellular organisms in which individual cells may be more or less specialised differentiated) for particular functions.
The individual units from which tissues of the body are formed. All living organisms are composed of one or more cells.
(26 Mar 1998)
regulatory cell proliferation kinase <enzyme> Involved in mitosis regulation; has characteristics of serine/threonine and tyrosine kinases; isolated from saccharomyces cerevisiae; genbank l08909
Registry number: EC 2.7.1.-
Synonym: rpk1 protein, rpk1 gene product
(26 Jun 1999)
regulatory T-cell <immunology> Vague term for any class of T lymphocyte not directly involved in the effector side of immunity, but involved in controlling responses and actions of other cells, especially T helper and T suppressor cells.
(18 Nov 1997)
glial cell <pathology> Specialised cells that surround neurons, providing mechanical and physical support and electrical insulation between neurons.
(17 Dec 1997)
C cell A cell of the pancreatic islets of the guinea pig.
Synonym: gamma cell of pancreas.
Synonym: parafollicular cells.
(05 Mar 2000)
globe cell anaemia <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane.
This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged.
Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal.
(27 Sep 1997)
globoid cell A large cell of mesodermal origin that is found clustered in the intracranial tissues in globoid cell leukodystrophy.
(05 Mar 2000)
globoid cell leukodystrophy <radiology> Dysmyelinating disease, autosomal recessive, usually presents by 1 yr, specific enzyme deficiency identified, rapid spontaneous nystagmus, poikilothermia
Synonym: Krabbe leukodystrophy
(12 Dec 1998)
CD4 cell T helper cells which are targets for HIV infection.
(09 Oct 1997)
CD4 cell count The most commonly used surrogate marker for assessing the state of the immune system. As CD4 cell count declines, the risk of developing opportunistic infections increases. The normal range for CD4 cell counts is 500 to 1500 per cubic millimetre of blood. CD4 count should be rechecked at least every six to twelve months if CD4s are greater than 500/mm3. If the count is lower, testing every three months is advised.
(09 Oct 1997)
virus-transformed cell A cell that has been genetically changed to a tumour cell, the change being subsequently tramsmitted to all descendent cell's; cell's transformed by oncornaviruses continue to produce virus in high concentration without being killed; DNA tumour virus-transformed cell's develop (along with other changes) tumour-associated antigens and rarely produce virus.
(05 Mar 2000)
CD8 cell <immunology> One type of T-lymphocyte which bears the CD8 molecular marker on its surface. Some CD8 cells recognise and kill cancerous cells and those infected by intracellular pathogens (some bacteria, viruses and mycoplasma). These cells are called cytotoxic T-lymphocytes (see).
(09 Oct 1997)
glomerulosa cell A cell of the zona glomerulosa of the adrenal cortex that is the source of aldosterone; the cell's are arranged in spherical or oval groups.
(05 Mar 2000)
cell <cell biology> An autonomous self replicating unit (in principle) that may constitute an organism (in the case of unicellular organisms) or be a sub unit of multicellular organisms in which individual cells may be more or less specialised differentiated) for particular functions.
The individual units from which tissues of the body are formed. All living organisms are composed of one or more cells.
(26 Mar 1998)
cell adhesion See: adhesins, cadherins, cell adhesion molecules (CAMs), contact sites A, DLVO theory, integrins, sorting out, uvomorulin and various specialised junctions (adherens junctions, desmosomes, focal adhesions, gap junction and zonula occludens).
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á